1. Home
  2. HKIT vs NTRB Comparison

HKIT vs NTRB Comparison

Compare HKIT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKIT

Hitek Global Inc.

HOLD

Current Price

$1.99

Market Cap

121.6M

Sector

Technology

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.43

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HKIT
NTRB
Founded
1996
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
71.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
HKIT
NTRB
Price
$1.99
$4.43
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
607.0K
23.1K
Earning Date
04-08-2026
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,812,901.00
$2,278,321.00
Revenue This Year
N/A
$30.17
Revenue Next Year
N/A
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.69
52 Week Low
$1.15
$3.72
52 Week High
$4.18
$11.78

Technical Indicators

Market Signals
Indicator
HKIT
NTRB
Relative Strength Index (RSI) 54.44 35.47
Support Level $1.42 $4.35
Resistance Level $2.59 $4.77
Average True Range (ATR) 0.20 0.42
MACD 0.08 0.02
Stochastic Oscillator 51.85 7.25

Price Performance

Historical Comparison
HKIT
NTRB

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: